Cresco Labs | SUNNYSIDE Stock
Ticker - CRLBF
Cresco Labs (Sunnyside) Stock Symbol - CRLBF
Cresco Labs Inc. cultivates, manufactures, and sells medical cannabis and medical cannabis products in several states including Florida. In 2021, they acquired One Plant by buying Bluma Wellness, a fan favorite, and rebranded under their flagship name, Sunnyside*. The recently acquired Columbia Care, a top Multi-State Operator (MSO) for 2B.
Headquarters: Chicago, IL
Industry: Drug Manufacturers – Specialty & Generic
Sector: Regulated Cannabis
FLD Homepage: Sunnyside*
Cresco Labs Sunnyside* | CRLBF Latest Stock News
CRLBF Stock Earnings: Cresco Labs Meets EPS, Beats Revenue for Q1 2024 – MSN
Read More
CRLBF Stock Earnings: Cresco Labs Meets EPS, Beats Revenue for Q1 2024 – InvestorPlace
Cresco Labs (OTCMKTS:CRLBF) just reported results for the first quarter of 2024. Cresco Labs reported earnings per share of -2 cents. This met the analyst estimate for EPS of -2 cents.The company reported revenue of $184.30 million.This was 0.58% better than the analyst estimate for revenue of $183.24 million. InvestorPlace Earnings is a project that
Cresco Labs Inc. Expected to Earn FY2024 Earnings of $0.00 Per Share (OTCMKTS:CRLBF) – Defense World
Cresco Labs Inc. (OTCMKTS:CRLBF – Free Report) – Equities researchers at Cormark upped their FY2024 earnings per share (EPS) estimates for shares of Cresco Labs in a report issued on Tuesday, May 21st. Cormark analyst J. Pytlak now anticipates that the company will post earnings of $0.00 per share for the year, up from their
Cormark Comments on Cresco Labs Inc.’s FY2024 Earnings (OTCMKTS:CRLBF) – MarketBeat
Cresco Labs Inc. (OTCMKTS:CRLBF – Free Report) – Equities research analysts at Cormark increased their FY2024 earnings per share (EPS) estimates for Cresco Labs in a research note issued on Tuesday, May 21st. Cormark analyst J. Pytlak now forecasts that the company will post earnings of $0.00 per share for the year, up from their
3 Cannabis Stocks That Could Be Millionaire-Makers: May Edition – Markets Insider
InvestorPlace – Stock Market News, Stock Advice & Trading Tips Cannabis stocks to buy are rallying after the U.S. Department of Justice proposed reclassifying marijuana as a less risky Schedule III drug. Following the DOJ’s proposal, President Biden came out on X, commending the move while signaling a rosier future for cannabis stocks. DOJ’s move essentially validates the decades-long
Marijuana Stocks Skyrocket Amidst Rescheduling Announcement
Since the HHS announcement on marijuana rescheduling, cannabis stocks have soared as investors gain renewed confidence in an industry that has been beleaguered by excessive regulation and taxation for years. According to New Cannabis Ventures’ Global Cannabis Stock Index, global cannabis stocks have skyrocketed over 20% since the announcement late last month. This is overall
